Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023657619> ?p ?o ?g. }
- W2023657619 endingPage "191" @default.
- W2023657619 startingPage "133" @default.
- W2023657619 abstract "The nicotinic acetylcholine receptor (AChR) presents two very well differentiated domains for ligand binding that account for different cholinergic properties. In the hydrophilic extracellular region of both α subunits there exist the binding sites for agonists such as the neurotransmitter acetylcholine (ACh) and for competitive antagonists such as d-tubocurarine. Agonists trigger the channel opening upon binding while competitive antagonists compete for the former ones and inhibit its pharmacological action. Identification of all residues involved in recognition and binding of agonist and competitive antagonists is a primary objective in order to understand which structural components are related to the physiological function of the AChR. The picture for the localisation of the agonist/competitive antagonist binding sites is now clearer in the light of newer and better experimental evidence. These sites are mainly located on both α subunits in a pocket approximately 30–35 Å above the surface membrane. Since both α subunits are sequentially identical, the observed high and low affinity for agonists on the receptor is conditioned by the interaction of the α subunit with the δ or the γ chain, respectively. This relationship is opposite for curare-related drugs. This molecular interaction takes place probably at the interface formed by the different subunits. The principal component for the agonist/competitive antagonist binding sites involves several aromatic residues, in addition to the cysteine pair at 192–193, in three loops-forming binding domains (loops A–C). Other residues such as the negatively charged aspartates and glutamates (loop D), Thr or Tyr (loop E), and Trp (loop F) from non-α subunits were also found to form the complementary component of the agonist/competitive antagonist binding sites. Neurotoxins such as α-, κ-bungarotoxin and several α-conotoxins seem to partially overlap with the agonist/competitive antagonist binding sites at multiple point of contacts. The α subunits also carry the binding site for certain acetylcholinesterase inhibitors such as eserine and for the neurotransmitter 5-hydroxytryptamine which activate the receptor without interacting with the classical agonist binding sites. The link between specific subunits by means of the binding of ACh molecules might play a pivotal role in the relative shift among receptor subunits. This conformational change would allow for the opening of the intrinsic receptor cation channel transducting the external chemical signal elicited by the agonist into membrane depolarisation. The ion flux activity can be inhibited by non-competitive inhibitors (NCIs). For this kind of drugs, a population of low-affinity binding sites has been found at the lipid–protein interface of the AChR. In addition, several high-affinity binding sites have been found to be located at different rings on the M2 transmembrane domain, namely luminal binding sites. In this regard, the serine ring is the locus for exogenous NCIs such as chlorpromazine, triphenylmethylphosphonium, the local anaesthetic QX-222, phencyclidine, and trifluoromethyliodophenyldiazirine. Trifluoromethyliodophenyldiazirine also binds to the valine ring, which is the postulated site for cembranoids. Additionally, the local anaesthetic meproadifen binding site seems to be located at the outer or extracellular ring. Interestingly, the M2 domain is also the locus for endogenous NCIs such as the neuropeptide substance P and the neurotransmitter 5-hydroxytryptamine. In contrast with this fact, experimental evidence supports the hypothesis for the existence of other NCI high-affinity binding sites located not at the channel lumen but at non-luminal binding domains. Among them, we can quote the binding site for exogenous NCIs such as quinacrine which is located at the lipid–protein interface of the αM1 domain, and ethidium which is believed to interact with the wall of the vestibule very far away from both the channel lumen and the lipid membrane surface. Additionally, endogenous NCIs such as progesterone, testosterone and glucocorticoids have been postulated to act through the lipid–protein interface or/and through the extracellular domain of the AChR. The most simple mechanism to describe the action of luminal NCIs is based on the assumption that these compounds enter the open channel, bind to different rings within the M2 transmembrane AChR domain, and block cation flux by sterically `plugging' the receptor pore. The existence of non-luminal NCI binding sites is not consistent with the open-channel-blocking mechanism. Instead, the presence of these kind of sites open the possibility for the regulation of cation permeation by an allosteric process. In turn, the allosteric mechanism can be viewed as the structural modification of the AChR channel by the binding of one NCI molecule to its specific high-affinity binding site. Within this perspective, although agonists at high concentrations resemble the pharmacological action of NCIs, the inhibitory binding site for agonists is postulated to be located at or close to the quinacrine locus. In turn, the quinacrine binding site is structurally related to the non-annular lipid domain of the AChR." @default.
- W2023657619 created "2016-06-24" @default.
- W2023657619 creator A5008550312 @default.
- W2023657619 date "1997-10-01" @default.
- W2023657619 modified "2023-10-18" @default.
- W2023657619 title "Topology of ligand binding sites on the nicotinic acetylcholine receptor" @default.
- W2023657619 cites W104057338 @default.
- W2023657619 cites W1213928540 @default.
- W2023657619 cites W137367789 @default.
- W2023657619 cites W1481524180 @default.
- W2023657619 cites W1482564031 @default.
- W2023657619 cites W1483481578 @default.
- W2023657619 cites W1491063837 @default.
- W2023657619 cites W1493038050 @default.
- W2023657619 cites W1494115702 @default.
- W2023657619 cites W1495493181 @default.
- W2023657619 cites W1495591448 @default.
- W2023657619 cites W1497103045 @default.
- W2023657619 cites W1497841468 @default.
- W2023657619 cites W1499528718 @default.
- W2023657619 cites W1500354613 @default.
- W2023657619 cites W1502429573 @default.
- W2023657619 cites W1503596186 @default.
- W2023657619 cites W1503781574 @default.
- W2023657619 cites W1505990424 @default.
- W2023657619 cites W1512225972 @default.
- W2023657619 cites W1515003936 @default.
- W2023657619 cites W1515181579 @default.
- W2023657619 cites W1516371256 @default.
- W2023657619 cites W1519445799 @default.
- W2023657619 cites W1522291368 @default.
- W2023657619 cites W1528191943 @default.
- W2023657619 cites W1529934127 @default.
- W2023657619 cites W1531561158 @default.
- W2023657619 cites W1534741036 @default.
- W2023657619 cites W1536136747 @default.
- W2023657619 cites W1539258258 @default.
- W2023657619 cites W1547554455 @default.
- W2023657619 cites W1548902459 @default.
- W2023657619 cites W1549306478 @default.
- W2023657619 cites W1549997811 @default.
- W2023657619 cites W1556409059 @default.
- W2023657619 cites W1559153735 @default.
- W2023657619 cites W1560768773 @default.
- W2023657619 cites W1560891849 @default.
- W2023657619 cites W1565016795 @default.
- W2023657619 cites W1574481985 @default.
- W2023657619 cites W1574849955 @default.
- W2023657619 cites W1577347730 @default.
- W2023657619 cites W1586090088 @default.
- W2023657619 cites W1587275242 @default.
- W2023657619 cites W1591899615 @default.
- W2023657619 cites W1595997248 @default.
- W2023657619 cites W1599005607 @default.
- W2023657619 cites W1599169471 @default.
- W2023657619 cites W1604384853 @default.
- W2023657619 cites W1606122936 @default.
- W2023657619 cites W1608817464 @default.
- W2023657619 cites W1615770114 @default.
- W2023657619 cites W1640605748 @default.
- W2023657619 cites W1643181266 @default.
- W2023657619 cites W1653903200 @default.
- W2023657619 cites W1658447938 @default.
- W2023657619 cites W1665596665 @default.
- W2023657619 cites W1672036172 @default.
- W2023657619 cites W170493551 @default.
- W2023657619 cites W177013919 @default.
- W2023657619 cites W1799536240 @default.
- W2023657619 cites W182807133 @default.
- W2023657619 cites W185231612 @default.
- W2023657619 cites W1865222991 @default.
- W2023657619 cites W1903420193 @default.
- W2023657619 cites W1907791554 @default.
- W2023657619 cites W1945141852 @default.
- W2023657619 cites W1958451483 @default.
- W2023657619 cites W1964143284 @default.
- W2023657619 cites W1964352423 @default.
- W2023657619 cites W1964737820 @default.
- W2023657619 cites W1965355471 @default.
- W2023657619 cites W1965439766 @default.
- W2023657619 cites W1965838804 @default.
- W2023657619 cites W1966504202 @default.
- W2023657619 cites W1966552570 @default.
- W2023657619 cites W1967040054 @default.
- W2023657619 cites W1967242463 @default.
- W2023657619 cites W1967631262 @default.
- W2023657619 cites W1967726807 @default.
- W2023657619 cites W1968031887 @default.
- W2023657619 cites W1968494676 @default.
- W2023657619 cites W1968686556 @default.
- W2023657619 cites W1968906607 @default.
- W2023657619 cites W1969154943 @default.
- W2023657619 cites W1969263740 @default.
- W2023657619 cites W1969856982 @default.
- W2023657619 cites W1970997492 @default.
- W2023657619 cites W1971009901 @default.
- W2023657619 cites W1971700403 @default.
- W2023657619 cites W1971970503 @default.